Senior scientists at the National Institutes of Health fear that research on conditions like obesity, heart disease and ...

Massachusetts General Hospital received $655 million in funding from the National Institutes of Health in fiscal 2024 — a slight decrease from the $675 million it secured in 2023, yet it remained the ...

Federal funding for biomedical research pays off by enabling basic discoveries that lead to lifesaving treatments, writes ...

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and development, particularly in clinical trials. The good news is that ...

Provide ready and sustained health services support and force health protection in support of the Total Force to enable readiness and to conserve the fighting strength while caring for our People ...

System Center delivers a simplified datacenter management experience to keep you in control of your IT—whether on-premises, in the cloud, or across platforms. It builds on the experience and depth of ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing with Pfizer, improved on fulvestrant in a subgroup of breast cancer patients, but not the overall study population.

There is emerging interest in adaptive platform trials for inflammatory bowel disease. In this Comment, we present the results of a workshop that was convened to consider the opportunities and ...

Mayo Clinic discovers new role for protein to fight tumors.